Association Between Triglycerides,High-Density Lipoprotein Cholesterol,and Their Ratio With the Pulse Wave Velocity in Adults From the ELSA-Brasil Study
Restricted accessResearch articleFirst published online October, 2023
Association Between Triglycerides,High-Density Lipoprotein Cholesterol,and Their Ratio With the Pulse Wave Velocity in Adults From the ELSA-Brasil Study
Atherogenic dyslipidemia is a risk factor for cardiovascular diseases. The present study aimed to evaluate the association between triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and the triglycerides to high-density lipoprotein (TG/HDL-C) ratio with carotid-femoral pulse wave velocity (cf-PWV), a marker of vascular stiffness. Anthropometric, biochemical, and clinical data from 13,732 adults were used to assess this association. Individuals within the third TG/HDL-C tertile presented worse anthropometric, biochemical, and clinical profiles as compared with the participants in the lower TG/HDL-C tertile. There was a linear association between TG, HDL-C, and TG/HDL-C ratio and cf-PWV in both men and women (stronger in women). After adjustment for confounders, lower levels of HDL-C were associated with increased cf-PWV in men (9.63 ± .02 m/s) and women (8.90 ± .03 m/s). However, TG was not significantly associated with cf-PWV after adjustment, regardless of sex. An increased TG/HDL-C ratio is associated with higher cf-PWV only in women (9.01 ± .03 m/s), but after adjustment for HDL-C levels, the association was non-significant (8.99 ± .03 m/s). These results highlight the stronger association of HDL-C with arterial stiffness, and that the association of TG/HDL-C with cf-PWV is dependent on HDL-C.
RothGAMensahGAJohnsonCO, et al.Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021.
2.
CatapanoALGrahamIDe BackerG, et al.ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999–3058.
3.
FruchartJCSantosRDAguilar-SalinasC, et al.The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: a consensus statement from the International atherosclerosis society (IAS) and the Residual risk reduction initiative (R3i) foundation. Cardiovasc Diabetol. 2019;18:71.
4.
FerenceBA. Causal effect of lipids and lipoproteins on atherosclerosis: lessons from genomic studies. Cardiol Clin. 2018;36:203–211.
5.
AndersonSGSandersTABCruickshankJK. Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension. 2009;53:839–845.
6.
WangFYePLuoL, et al.Association of serum lipids with arterial stiffness in a population-based study in Beijing. Eur J Clin Invest. 2011;41:929–936.
7.
McEnieryCMSprattMMunneryM, et al.An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension. 2010;56:36–43.
8.
AmarJRuidavetsJBChamontinBDrouetLFerrieJResÁ. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens. 2001;19:381–387.
9.
VlachopoulosCAznaouridisKStefanadisC. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol2010;55:1318–1327.
10.
AlvimROSantosPCJLBortolottoLAMillJGPereiraAC. Arterial stiffness: pathophysiological and genetic aspects. Int J Cardiovasc Sci. 2017;30:433–441.
11.
HelkinASteinJJLinSSiddiquiSMaierKGGahtanV. Dyslipidemia part 1 - review of lipid metabolism and vascular cell physiology. Vasc Endovasc Surg. 2016;50:107–118.
12.
BothamKMMooreEHPascaleCBejtaF. The induction of macrophage foam cell formation by chylomicron remnants. Biochem Soc Trans. 2007;35:454–458.
13.
MillerMStoneNJBallantyneC, et al.Triglycerides and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2011;123:2292–2333.
14.
WangXDuYFanL, et al.Relationships between HDL-C, hs-CRP, with central arterial stiffness in apparently healthy people undergoing a general health examination. PLoS One. 2013;8:e81778.
15.
LelisDCalzavaraJSantosR, et al.Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: the ELSA-Brasil study. J Clin Lipidol. 2021;15:699–711.
16.
Murguía-RomeroMJiménez-FloresJRSigrist-FloresSC, et al.Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res. 2013;54:2795–2799.
17.
SchmidtMIDuncanBBMillJG, et al.Cohort profile: longitudinal study of adult health (ELSA-Brasil). Int J Epidemiol. 2015;44:68–75.
18.
AquinoEMLBarretoSMBensenorIM, et al.Brazilian longitudinal study of adult health (ELSA-Brasil): objectives and design. Am J Epidemiol. 2012;175:315–324.
19.
MillJGPintoKGriepRH, et al.Medical assessments and measurements in ELSA-Brasil. Rev Saude Publica. 2013;47:54–62.
20.
VeroneseFVGomesECChananJ, et al.Performance of CKD-EPI equation to estimate glomerular filtration rate as compared to MDRD equation in South Brazilian individuals in each stage of renal function. Clin Chem Lab Med. 2014;52:1747–1754.
21.
MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
22.
BaldoMPCunhaRSMolinaMCB, et al.Carotid-femoral pulse wave velocity in a healthy adult sample: the ELSA-Brasil study. Int J Cardiol. 2018;251:90–95.
23.
BaldoMPCunhaRSRibeiroALP, et al.Racial differences in arterial stiffness are mainly determined by blood pressure levels: results from the ELSA-Brasil study. J Am Heart Assoc. 2017;6:e005477.
24.
WangXYePCaoR, et al.Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study. Lipids Health Dis. 2016;15:1–9.
25.
AznaouridisKVlachopoulosCDimaIIoakeimidisNStefanadisC. Triglyceride level is associated with wave reflections and arterial stiffness in apparently healthy middle-aged men. Heart. 2007;93:613–614.
26.
NakanishiNShiraishiTWadaM. Brachial-Ankle pulse wave velocity and metabolic syndrome in a Japanese population: the Minoh study. Hypertens Res. 2005;28:125-131.
27.
CeceljaMChowienczykP. Blood vessels dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension a systematic review selection criteria. Hypertension. 2009;54:1328–1336.
28.
PascotALemieuxIBergeronJ, et al.HDL particle size: a marker of the gender difference in the metabolic risk profile. Atherosclerosis. 2002;160:399–406.
29.
TallA. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J Intern Med. 1995;237:5–12.
30.
LamarcheBUffelmanKDCarpentierA, et al.Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest. 1999;103:1191-1199.
31.
ShuheiNSöderlundSJauhiainenMTaskinenMR. Effect of HDL composition and particle size on the resistance of HDL to the oxidation. Lipids Health Dis. 2010;9:1–10.
32.
AlagonaCSoroAWesterbackaJ, et al.Low HDL cholesterol concentration is associated with increased intima-media thickness independent of arterial stiffness in healthy subjects from families with low HDL cholesterol. Eur J Clin Invest. 2003;33:457–463.
33.
ChangJBChuNFSyuJTHsiehATHungYR. Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients. Lipids Health Dis. 2011;10:1–7.
34.
ShenWCLuFHYangYC, et al.The relationship between high-density lipoprotein cholesterol levels and arterial stiffness in a Taiwanese population. Nutr Metabol Cardiovasc Dis. 2017;27:1136–1142.
35.
RoesSDDehnaviRAWestenbergJJM, et al.Assessment of aortic pulse wave velocity and cardiac diastolic function in subjects with and without the metabolic syndrome: HDL cholesterol is independently associated with cardiovascular function. Diabetes Care. 2008;31:1442-1444.
36.
HavlikRJBrockDLohmanK, et al.High-density lipoprotein cholesterol and vascular stiffness at baseline in the activity counseling trial. Am J Cardiol. 2001;87:104–107.
37.
LebrunCEISchouwYTVDBakAAA, et al.Arterial stiffness in postmenopausal women: determinants of pulse wave velocity. J Hypertens. 2002;20:2165–2172.
38.
TsioufisCTsiachrisDDimitriadisK, et al.Evidence for no global effect of metabolic syndrome per se on early hypertensive sequelae. J Hypertens. 2008;26:773–779.
39.
MiaoDMYePXiaoWKGaoPZhangJYWuHM. Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic dysfunction in essential hypertension. J Clin Hypertens. 2011;13:710–715.
40.
BenerosAAdamopoulosCBureauJM, et al.Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002;105:1202–1207.
41.
DartAMGatzkaCDCameronJD, et al.Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol. 2004;24:962–968.
42.
AlvimROMourao-JuniorCAMagalhãesGL, et al.Non-HDL cholesterol is a good predictor of the risk of increased arterial stiffness in postmenopausal women in an urban Brazilian population. Clinics. 2017;72:106–110.
43.
MillánJPintóXMuñozA, et al.Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757-765.
44.
MartinRSHoracioACWalterGE, et al.Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects. J Am Soc Hypertens. 2014;8:724–731.
45.
McLaughlinTAbbasiFChealKChuJLamendolaCReavenG. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139:802–809.
46.
ShinHGKimYKKimYHJungYHKangHC. The relationship between the triglyceride to high-density lipoprotein cholesterol ratio and metabolic syndrome. Korean J Fam Med. 2017;38:352–357.
47.
ValléeALelongHLopez-SubletMTopouchianJSafarMEBlacherJ. Association between different lipid parameters and aortic stiffness. J Hypertens. 2019;37:2240–2246.
48.
ChenCDaiJL. Triglyceride to high-density lipoprotein cholesterol (HDL-C) ratio and arterial stiffness in Japanese population: a secondary analysis based on a cross-sectional study. Lipids Health Dis. 2018;17:1–9.
49.
WenJHZhongYYWenZG, et al.Triglyceride to HDL-C ratio and increased arterial stiffness in apparently healthy individuals. Int J Clin Exp Med. 2015;8:4342–4348.
50.
TanakaHMunakataMKawanoY, et al.Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022–2027.
51.
WenJZhongYKuangCLiaoJChenZYangQ. Lipoprotein ratios are better than conventional lipid parameters in predicting arterial stiffness in young men. J Clin Hypertens. 2017;19:771–776.
52.
UrbinaEMKhouryPRMcCoyCEDolanLMDanielsSRKimballTR. Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics. 2013;131:e1082–e1090.
53.
ShimizuYNakazatoMSekitaT, et al.Association of arterial stiffness and diabetes with triglycerides-to-HDL cholesterol ratio for Japanese men: the Nagasaki Islands study. Atherosclerosis. 2013;228:491–495.
54.
ZitnanovaIOravecSJanubovaM, et al.Gender differences in LDL and HDL subfractions in atherogenic and nonatherogenic phenotypes. Clin Biochem. 2020;79:9–13.
55.
PalmisanoBTZhuLEckelRHStaffordJM. Sex differences in lipid and lipoprotein metabolism. Mol Metabol. 2018;15:45–55.
56.
Tilly-KiesiMLichtensteinAHJovenJ, et al.Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI: AII in older subjects. Arterioscler Thromb Vasc Biol. 1997;17:3513–3518.
57.
MitchellGFPariseHBenjaminEJ, et al.Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham heart study. Hypertension. 2004;43:1239–1245.
